A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
Open to Accrual
Date Opened To Accrual
August 26 2019
To examine if letrozole monotherapy/maintenance is non-inferior to IV paclitaxel/carboplatin and maintenance letrozole with respect to PFS in women with stage II-IV primary low-grade serous carcinoma of the ovary or peritoneum after primary surgical cytoreduction.
Women with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum after primary surgical cytoreduction.
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.